Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice
about
Effects of NSAIDs on the risk factors of colorectal cancer: a mini reviewPlasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic TestingObesity as an important risk factor for certain types of cancerThe Differential Effect of Toxoplasma Gondii Infection on the Stability of BCL2-Family Members Involves Multiple Activities.C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms.Protective role of hesperidin against γ-radiation-induced oxidative stress and apoptosis in rat testis.Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic functionModulators of the urokinase-type plasminogen activation system for cancer.High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men.Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.Chemoprevention of colorectal cancer in inflammatory bowel disease.Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.High susceptibility to zymbal gland and intestinal carcinogenesis in diabetic Otsuka long-evans Tokushima Fatty rats.Association between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms.SK-216, a Novel Inhibitor of Plasminogen Activator Inhibitor-1, Suppresses Lung Metastasis of Human Osteosarcoma.
P2860
Q26746884-131DB98A-C7F1-4AC9-B96F-10FE6C357853Q26801060-1E5026C7-81DC-40CE-A55E-47B48EB63FA0Q34082428-4543781A-D361-4B11-88FB-030F628386B7Q35029111-AEE51282-9A2B-4BA8-AA54-1471402D252DQ35600230-FF8B135C-F7C5-4F7F-86B1-5937B9DEC8A3Q36298996-35E7F857-C2D8-4A1E-9E27-3F3627DF61F0Q36486880-AC2EAD0A-62F7-4E52-81F7-0ADDF264E813Q37733590-BDDF7EDF-732C-4D7F-8AB1-CAD4A031676EQ38340427-CC6D8776-3888-4955-8D56-7A3BF651E881Q38407367-5E4AAA7D-6E5B-4647-A7F6-FF05B5E7AE3BQ38912093-E04A6516-B488-4DF1-9135-AE605C997DE5Q39016806-2093A094-5461-4E31-88D1-5FE0722F6CBDQ39441083-FA478F5B-3E14-4C7B-8C6A-ED21F51C279BQ40665279-F5265F61-FBB8-4472-8E32-73E666313767Q42969107-883EDF31-2320-47CB-9F99-7EF23F84E5A7Q52671448-EFE07833-7551-47A7-BF04-32106C77E9FB
P2860
Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice
description
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im April 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/04/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/04/01)
@nl
наукова стаття, опублікована у квітні 2008
@uk
مقالة علمية (نشرت في أبريل 2008)
@ar
name
Plasminogen activator inhibito ...... al polyp formation in Min mice
@ast
Plasminogen activator inhibito ...... al polyp formation in Min mice
@en
Plasminogen activator inhibito ...... al polyp formation in Min mice
@nl
type
label
Plasminogen activator inhibito ...... al polyp formation in Min mice
@ast
Plasminogen activator inhibito ...... al polyp formation in Min mice
@en
Plasminogen activator inhibito ...... al polyp formation in Min mice
@nl
prefLabel
Plasminogen activator inhibito ...... al polyp formation in Min mice
@ast
Plasminogen activator inhibito ...... al polyp formation in Min mice
@en
Plasminogen activator inhibito ...... al polyp formation in Min mice
@nl
P2093
P3181
P356
P1433
P1476
Plasminogen activator inhibito ...... al polyp formation in Min mice
@en
P2093
Keiji Wakabayashi
Kentaro Ueda
Kiyoshi Nakatogawa
Mami Takahashi
Masami Komiya
Michihiro Mutoh
Naoko Niho
Rina Ohtsubo
Takashi Sugimura
P304
P3181
P356
10.1093/CARCIN/BGN028
P407
P577
2008-04-01T00:00:00Z